https://www.astracapital.net.au/blogs/astra-capital-insights/beautys-big-roll-ups-are-running-out-of-road-thats-good-news-for-founders-in-the-lower-mid-market 2026-08-10T16:55:57+10:00 weekly https://www.astracapital.net.au/blogs/astra-capital-insights/while-australia-watches-the-big-healthcare-deals-the-real-action-is-in-the-clinics-nobodys-coverin 2026-08-10T16:50:30+10:00 weekly https://www.astracapital.net.au/blogs/astra-capital-insights/the-bolt-on-tax-what-australias-new-merger-regime-means-for-specialty-retail-roll-ups 2026-08-10T17:03:57+10:00 weekly https://www.astracapital.net.au/blogs/astra-capital-insights/recurring-revenue-is-becoming-the-real-currency-of-anz-wellness-and-beauty 2026-08-10T17:03:45+10:00 weekly https://www.astracapital.net.au/blogs/white-papers/is-adore-beauty-a-good-opportunity 2026-08-20T10:24:06+10:00 weekly https://cdn.shopify.com/s/files/1/1041/1248/8731/articles/images_12cef0b8-4a3b-48a2-a52d-faa3e6a54761.png?v=1787185446 Is Adore Beauty a Good Opportunity? https://www.astracapital.net.au/blogs/white-papers/is-vitura-health-a-turnaround-in-progress-or-a-value-trap 2026-08-20T09:23:10+10:00 weekly https://cdn.shopify.com/s/files/1/1041/1248/8731/articles/image.png?v=1787181790 Is Vitura Health a Turnaround in Progress, or a Value Trap? https://www.astracapital.net.au/blogs/white-papers/is-cochlear-a-reset-opportunity-or-a-structural-slowdown 2026-08-20T10:23:42+10:00 weekly https://cdn.shopify.com/s/files/1/1041/1248/8731/articles/COCHLEAR_IMAGE.png?v=1787185422 Is Cochlear a Reset Opportunity or a Structural Slowdown? https://www.astracapital.net.au/blogs/white-papers/is-csls-reset-the-bottom-or-the-start-of-a-longer-story 2026-08-20T10:22:58+10:00 weekly https://cdn.shopify.com/s/files/1/1041/1248/8731/articles/CSL_f974c322-3487-437c-ab29-b9b7f88aed25.png?v=1787185378 Is CSL's Reset the Bottom, or the Start of a Longer Story? https://www.astracapital.net.au/blogs/astra-capital-insights/the-budget-didnt-kill-negative-gearing-it-redirected-the-capital 2026-10-09T12:36:55+10:00 weekly https://www.astracapital.net.au/blogs/white-papers/is-fisher-amp-paykel-healthcares-tariff-playbook-a-model-for-anz-medtech 2026-08-23T23:56:13+10:00 weekly https://cdn.shopify.com/s/files/1/1041/1248/8731/articles/image_4b4a36e0-ce48-476e-91f7-2e599be44c5f.png?v=1787493373 Is Fisher & Paykel Healthcare's Tariff Playbook a Model for ANZ Medtech? https://www.astracapital.net.au/blogs/white-papers/is-epsilon-healthcare-a-good-opportunity 2026-10-09T13:03:48+10:00 weekly https://cdn.shopify.com/s/files/1/1041/1248/8731/articles/Epsilon_Healthcare.png?v=1788438099 Is Epsilon Healthcare a Good Opportunity? https://www.astracapital.net.au/blogs/white-papers/what-yo-chis-global-expansion-says-about-scaling-founder-led-retail-concepts-without-franchising-them-away 2026-10-09T13:01:36+10:00 weekly https://cdn.shopify.com/s/files/1/1041/1248/8731/articles/YoChiLogo-1920w.webp?v=1791514853 What Yo-Chi's global expansion says about scaling founder-led retail concepts without franchising them away